Centiva Capital’s Anterix ATEX Stock Holding History

Centiva Capital’s Portfolio ATEX Stock Details ATEX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-6,888	Closed	-$252K	–	1521
2025 Q1	$252K	Buy	+6,888	New	+$237K	0.01%	1174
2024 Q4	–	Sell	-11,805	Closed	-$445K	–	1668
2024 Q3	$445K	Buy	+11,805	New	+$455K	0.01%	1326

Other funds holding ATEX

OCAM

Owl Creek Asset Management New York $1.21B AUM 169.99% 1-Year Est. Return

HCL

Heard Capital LLC Chicago, Illinois $2.34B AUM 46.76% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DCM

DG Capital Management New York $475M AUM 36.12% 1-Year Est. Return

QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return

GECH

Garnet Equity Capital Holdings New York $530M AUM 69.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Centiva Capital's ATEX Position: Q2 2025 in Review

Centiva Capital sold out of Anterix (ATEX) in Q2 2025, closing a stake of 6,888 shares — an estimated $252K sold.

Centiva Capital first reported a position in ATEX in Q3 2024 and held it in 2 quarters. The position peaked at $445K in Q3 2024. 111 funds tracked by Wall St. Rank hold ATEX as of Q2 2025.

Centiva Capital reported no remaining Anterix position as of Q2 2025 after selling out during the quarter.
Centiva Capital sold 6,888 Anterix shares in Q2 2025, an estimated $252K.
Centiva Capital first reported a position in Anterix in Q3 2024 and held it in 2 quarters.
Centiva Capital's Anterix position peaked at $445K in Q3 2024.
111 funds tracked by Wall St. Rank held Anterix as of Q2 2025.

Based on Centiva Capital's 13F filing for Q2 2025, filed 13 Aug 2025.